Latest Advisory

  • FDA Advisory No. 2016-105 || Public Health Warning Against the Use of Unnotified Cosmetic Products

    FDA Advisory No. 2016-105 || Public Health Warning Against the Use of Unnotified Cosmetic Products

    Read more

  • FDA Advisory No. 2016-104-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-104-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-104 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-104 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2016-103-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-103-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-103 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-103 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

Administrative Order 2016-0003

Guidelines on the Unified Licensing Requirements and Procedure of the Food and Drug Administration (FDA)

I. RATIONALE

The 1987 Philippine Constitution mandates the establishment of an effective food and drug regulatory system that is responsive to the country's health needs and problems.

Consistent with said constitutional provision, Congress passed landmark legislations, namely Republic Act (RA) No. 3720 (Food, Drugs and Devices and Cosmetics Act), as amended by RA No. 9711 (Food and Drug Administration Act of 2009), RA No. 10611 (Food Safety Act of 2013), and RA No. 9502 Universally Accessible Cheaper and Quality Medicine Act of 2008) mandating FDA to regulate establishments engaged in health products to ensure consumer safety, welfare protection, and fair practice

 

To continue reading download the attachment...

More Articles ...

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter